NCI SBIR and STTR - Advancing the Commercialization of New Cancer Innovations

NCI SBIR and STTR - Advancing the Commercialization of New Cancer Innovations

NCI SBIR and STTR:

Advancing the Commercialization

of New Cancer Innovations​

​A lecture presented by Ming Zhao, PhD, Program Director

SBIR Development Center, National Cancer Institute

MingZhao.png

Wednesday, August 27, 2014

Noon–1pm

Innovation Depot – Training Room

1500 1st Ave N, Birmingham, AL 35203

 

This session will provide an overview of:

-        SBIR/STTR eligibility requirements

-        NIH SBIR/STTR process and new cancer-focused grant funding opportunities from NCI

-        New NCI SBIR/STTR initiatives

-        Practical strategies and tips on how to successfully submit competitive research proposals

 

Ming Zhao, Ph.D., is a Program Director in the SBIR Development Center at the National Cancer Institute (NCI).  In this role, Dr. Zhao develops and manages SBIR/STTR programs and contracts focused on cancer therapeutics, molecular diagnostics and medical imaging.  Prior to his appointment at SBIR, Dr. Zhao was a Program Director in the Center to Reduce Cancer Health Disparities (CRCHD) at the NCI.  During his tenure at CRCHD, he managed various NCI/NIH programs such as Community Networks Program Centers (CNPC, a program with a total of $117M & 23 Centers) and Geographical Management of Cancer Health Disparities Program (GMaP) as well as R01/R21 grants.   Before Dr Zhao joined NCI, he worked as a senior scientist at the GE Global Research Center and as a scientist at Pfizer.  Dr. Zhao has broad industrial experience in the development of molecular medicine for early diagnosis of cancer, molecular imaging, the application of human embryonic stem cells, bioinformatics, DNA cloning without cells, biological assay development for bio-compatibility in healthcare applications, and drug discovery in cancer, diabetes, obesity, and central nervous system diseases.  Dr. Zhao received his BS/MS degrees from Shandong University, China, and his Ph.D. in molecular biology and biochemistry from the Department of Biological Sciences, Wayne State University.  He carried out postdoctoral research at both the University of Michigan Medical School and Wayne State University.  Dr. Zhao has published over fifty scientific publications and industrial/technical reports.  He has also filed/published eight patents.

Opportunities for one-on-one meetings with Dr. Ming Zhao are available for attendees.  If interested in scheduling a one-on-one meeting, please contact Jennifer Croker, PhD (jcroker@uab.edu) before COB, Friday, August 22.

 

Registration is free – Space is limited. To learn more and to reserve your spot, please visit: https://www.eventbrite.com/e/nci-sbir-sttr-advancing-the-commercialization-of-new-cancer-innovations-tickets-12512891395​


​​